MEI Pharma
MEIP
MEIP
49 hedge funds and large institutions have $99.4M invested in MEI Pharma in 2013 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 26 increasing their positions, 6 reducing their positions, and 10 closing their positions.
Holders
49
Holders Change
+1
Holders Change %
+2.08%
% of All Funds
1.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
26
Reduced
6
Closed
10
Calls
$216K
Puts
–
Net Calls
+$216K
Net Calls Change
-$343K
Top Buyers
| 1 |
O
1
OrbiMed
New York
|
$15.9M |
| 2 |
2
Fidelity Investments
Boston,
Massachusetts
|
$25.8M |
| 3 |
VAM
3
Visium Asset Management
New York
|
$9.88M |
| 4 |
4
JPMorgan Chase & Co
New York
|
$5.55M |
| 5 |
DM
5
Deerfield Management
New York
|
$10M |
Top Sellers
| 1 |
BBA
1
Baker Bros. Advisors
New York
|
$0 |
| 2 |
2
Invesco
Atlanta,
Georgia
|
$0 |
| 3 |
WC
3
Wexford Capital
West Palm Beach,
Florida
|
$1.89M |
| 4 |
4
Jane Street
New York
|
$0 |
| 5 |
5
SG Americas Securities
New York
|
$0 |
